Dual Kinase/Demethylase as Inhibitors of Proliferative Diseases

Researchers at Purdue University have developed compounds as first-in-class dual kinase/demethylase inhibitors with the potential to inhibit cancer cell proliferation. In addition to cancer, these inhibitors are useful in the treatment of other diseases such as inflammation, viral and bacterial infections, and neurological and immunological disorders. In various tests, this inhibitor affected cancer cells without harming noncancerous cells, which helps prevent drug rejection or other issues typically seen in cancer treatment. As research continues, these inhibitors show promise as the next generation of cancer treatment.

First-in-class inhibitors Promising early tests Does not affect noncancerous cells

Drug development Pharmaceutical industry Treatment of cancer and other diseases

United States

None

USA